minoxidil has been researched along with spironolactone in 42 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (14.29) | 18.7374 |
| 1990's | 3 (7.14) | 18.2507 |
| 2000's | 10 (23.81) | 29.6817 |
| 2010's | 18 (42.86) | 24.3611 |
| 2020's | 5 (11.90) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Oparil, S; Rick, JH | 1 |
| Riddiough, MA | 1 |
| Brunner, HR; Ferguson, RK; Gavras, H; Jaeger, P; Jéquier, E; Turini, GA | 1 |
| Kincaid-Smith, P | 1 |
| Finnerty, FA | 1 |
| Biffignandi, P; Massucchetti, C; Molinatti, GM | 1 |
| Callan, AW; Montalto, J | 1 |
| Price, VH; Shapiro, J | 1 |
| Sinclair, RD; Tran, D | 1 |
| Olsen, EA | 1 |
| Hannuksela, M | 2 |
| Bandaranayake, I; Mirmirani, P | 1 |
| Bergfeld, WF; Hordinsky, MK; Messenger, AG; Olsen, EA; Roberts, JL; Shapiro, J; Stough, D; Washenik, K; Whiting, DA | 1 |
| Hoedemaker, C; Sinclair, R; van Egmond, S | 1 |
| Scheinfeld, N | 1 |
| Rathnayake, D; Sinclair, R | 1 |
| Black, HR; Slim, HB; Thompson, PD | 1 |
| Sinclair, R; Yazdabadi, A | 1 |
| Dickson, GM | 1 |
| Bessis, D; Dereure, O; Frouin, E; Guillot, B; Jacot, W; Kluger, N; Poujol, S; Rigau, V; Romieu, G | 1 |
| Adenuga, P; Bergfeld, W; Summers, P | 1 |
| Bechtel, MA; Harfmann, KL | 1 |
| Ioannides, D; Lazaridou, E | 1 |
| Vary, JC | 1 |
| Antunes, I; Magalhães, S; Pereira, N; Rodrigues, M | 1 |
| Sinclair, RD | 1 |
| Chan, L; Cook, DK | 1 |
| Azziz, R; Bergfeld, W; Carmina, E; Escobar-Morreale, HF; Futterweit, W; Huddleston, H; Lobo, R; Olsen, E | 1 |
| Chan, D; Cho, J; Cigler, T; Fabbrocini, G; Freites-Martinez, A; Gajria, D; Goldfarb, S; Lacouture, ME; Modi, S; Norton, L; Paus, R; Shapiro, J; Sibaud, V; Tosti, A | 1 |
| Abdel-Aziz, RTA; Abdel-Raouf, H; Ahmed, SS; Aly, UF; Medhat, W | 1 |
| Craiglow, BG; Olamiju, B | 1 |
| Baussard, L; Fiteni, F; Guichard, A; Le Vigouroux, S; Quesada, S | 1 |
| Abdel-Dayem, HA; Ammar, AM; Elsaie, ML; Elshahid, AR; Mohamed, AA | 1 |
| Deoghare, S; Sadick, NS | 1 |
17 review(s) available for minoxidil and spironolactone
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Preventing, detecting and managing adverse reactions of antihypertensive agents in the ambulant patient with essential hypertension.
Topics: Antihypertensive Agents; Benzothiadiazines; Clonidine; Diuretics; Drug Interactions; Ethacrynic Acid; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Prazosin; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone | 1977 |
[Intracellular and extracellular proteins binding androgenic hormones. Biochemical properties and clinical significance].
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Androgen-Binding Protein; Androgen-Insensitivity Syndrome; Breast Neoplasms; Carrier Proteins; Danazol; Disorders of Sex Development; Female; Humans; Hyperthyroidism; Infertility, Male; Liver Cirrhosis; Male; Minoxidil; Receptors, Androgen; Sex Hormone-Binding Globulin; Spironolactone | 1983 |
Female androgenetic alopecia: an update.
Topics: Alopecia; Androgens; Cyproterone Acetate; Female; Humans; Minoxidil; Prognosis; Spironolactone | 1995 |
Hair regrowth. Therapeutic agents.
Topics: Administration, Topical; Adrenal Cortex Hormones; Adult; Alopecia; Alopecia Areata; Androgen Antagonists; Animals; Anthralin; Anti-Inflammatory Agents; Child; Cyproterone Acetate; Drug Therapy, Combination; Enzyme Inhibitors; Female; Finasteride; Hair; Humans; Male; Minoxidil; PUVA Therapy; Spironolactone | 1998 |
Understanding and managing common baldness.
Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Female; Finasteride; Hair; Humans; Incidence; Male; Minoxidil; Sex Distribution; Spironolactone; Treatment Outcome | 1999 |
[Loss of hair].
Topics: Alopecia; Androgen Antagonists; Cyproterone Acetate; Enzyme Inhibitors; Female; Finasteride; Hair; Hormone Antagonists; Humans; Male; Minoxidil; Sex Factors; Spironolactone; Surgery, Plastic; Treatment Outcome | 2000 |
Hair loss remedies--separating fact from fiction.
Topics: Alopecia; Azasteroids; Dietary Supplements; Dutasteride; Enzyme Inhibitors; Female; Finasteride; Humans; Low-Level Light Therapy; Male; Mineralocorticoid Receptor Antagonists; Minoxidil; Spironolactone; Treatment Outcome; Vasodilator Agents | 2004 |
[The treatment of female pattern hair loss].
Topics: Administration, Oral; Administration, Topical; Adult; Age Distribution; Alopecia; Female; Finland; Follow-Up Studies; Humans; Incidence; Middle Aged; Minoxidil; Risk Factors; Severity of Illness Index; Spironolactone | 2006 |
A review of hormonal therapy for female pattern (androgenic) alopecia.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Androgens; Cyproterone Acetate; Dermatologic Agents; Enzyme Inhibitors; Female; Finasteride; Flutamide; Humans; Minoxidil; Spironolactone; Testosterone | 2008 |
Older blood pressure medications-do they still have a place?
Topics: Antihypertensive Agents; Chlorthalidone; Clonidine; Diuretics; Ethacrynic Acid; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Reserpine; Spironolactone; Vasodilator Agents | 2011 |
Hair loss in women.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Female; Finasteride; Flutamide; Hair; Humans; Hypotrichosis; Minoxidil; Phototherapy; Spironolactone; Vasodilator Agents | 2015 |
Female pattern hair loss.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Alopecia; Androgen Antagonists; Androgen Receptor Antagonists; Antifungal Agents; Cyproterone Acetate; Dutasteride; Female; Finasteride; Flutamide; Hair; Humans; Ketoconazole; Minoxidil; Postmenopause; Spironolactone; Vasodilator Agents | 2015 |
Selected Disorders of Skin Appendages--Acne, Alopecia, Hyperhidrosis.
Topics: Acetylcholine Release Inhibitors; Acne Vulgaris; Algorithms; Alopecia; Anti-Bacterial Agents; Antiperspirants; Benzoyl Peroxide; Botulinum Toxins; Contraceptives, Oral, Hormonal; Dermatologic Agents; Finasteride; Hair Follicle; Humans; Hyperhidrosis; Iontophoresis; Mandelic Acids; Minoxidil; Muscarinic Antagonists; Nails; Retinoids; Spironolactone; Sweat Glands; Sympathectomy | 2015 |
Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.
Topics: 5-alpha Reductase Inhibitors; Alopecia; Androgen Antagonists; Female; Humans; Hyperandrogenism; Low-Level Light Therapy; Mineralocorticoid Receptor Antagonists; Minoxidil; Platelet-Rich Plasma; Polycystic Ovary Syndrome; Scalp; Spironolactone; Vasodilator Agents | 2019 |
[Alopecia and cancers: From basics to clinical practice].
Topics: Alopecia; Antihypertensive Agents; Antineoplastic Agents; Bimatoprost; Hair; Hair Follicle; Humans; Iatrogenic Disease; Immunotherapy; Minoxidil; Molecular Targeted Therapy; Neoplasms; Quality of Life; Radiotherapy; Scalp Dermatoses; Spironolactone | 2021 |
Combination therapy in female pattern hair loss.
Topics: Alopecia; Combined Modality Therapy; Female; Finasteride; Humans; Minoxidil; Spironolactone; Treatment Outcome | 2023 |
1 trial(s) available for minoxidil and spironolactone
| Article | Year |
|---|---|
A novel topical combination of minoxidil and spironolactone for androgenetic alopecia: Clinical, histopathological, and physicochemical study.
Topics: Administration, Topical; Alopecia; Drug Therapy, Combination; Hair; Humans; Minoxidil; Scalp; Spironolactone; Treatment Outcome | 2021 |
24 other study(ies) available for minoxidil and spironolactone
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Drug treatment of hypertension.
Topics: Clonidine; Diazoxide; Diuretics; Ganglionic Blockers; Guanethidine; Humans; Hydralazine; Hypertension; Mecamylamine; Methyldopa; Mineralocorticoid Receptor Antagonists; Minoxidil; Nitroprusside; Prazosin; Propranolol; Secologanin Tryptamine Alkaloids; Sodium Chloride Symporter Inhibitors; Spironolactone; Sympatholytics; Triamterene; Trimethaphan; Vasodilator Agents | 1977 |
[Long-term minoxidil therapy: renin, aldosterone, noradrenaline and the need for beta blockers].
Topics: Adult; Aldosterone; Chlorthalidone; Female; Furosemide; Hirsutism; Humans; Hypertension; Male; Middle Aged; Minoxidil; Norepinephrine; Oxprenolol; Propranolol; Pyrimidines; Renin; Spironolactone; Water-Electrolyte Balance | 1978 |
Management of severe hypertension.
Topics: Benzothiadiazines; Blood Pressure; Clonidine; Diazoxide; Diet, Sodium-Restricted; Disseminated Intravascular Coagulation; Ethanolamines; Female; Glomerular Filtration Rate; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Pre-Eclampsia; Pregnancy; Propranolol; Renin; Sodium; Spironolactone | 1973 |
Drugs used in the treatment of hypertension.
Topics: Administration, Oral; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Ethacrynic Acid; Ferricyanides; Furosemide; Guanethidine; Humans; Hydralazine; Hypertension; Methyldopa; Minoxidil; Nitric Oxide; Propranolol; Reserpine; Sodium Chloride Symporter Inhibitors; Spironolactone; Triamterene; Vasodilator Agents | 1973 |
My hair is thinning on the top of my head. What treatments are available for hair loss in women?
Topics: Alopecia; Diuretics; Enzyme Inhibitors; Female; Finasteride; Humans; Minoxidil; Spironolactone; United States; Vasodilator Agents | 2002 |
Evaluation and treatment of male and female pattern hair loss.
Topics: 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Administration, Topical; Adolescent; Adult; Alopecia; Androgen Antagonists; Contraindications; Cosmetic Techniques; Cyproterone Acetate; Diagnosis, Differential; Dihydrotestosterone; Female; Finasteride; Gonadal Steroid Hormones; Hair; Hair Follicle; Humans; Hypothyroidism; Iron Deficiencies; Isoenzymes; Male; Middle Aged; Minoxidil; Receptors, Androgen; Sex Characteristics; Spironolactone | 2005 |
Treatment of female pattern hair loss with a combination of spironolactone and minoxidil.
Topics: Administration, Cutaneous; Administration, Oral; Alopecia; Drug Therapy, Combination; Female; Humans; Middle Aged; Mineralocorticoid Receptor Antagonists; Minoxidil; Spironolactone; Vasodilator Agents | 2007 |
Treating female pattern hair loss. Noticeable hair loss can be deeply distressing. Here are some medical treatments that may help.
Topics: Administration, Cutaneous; Administration, Oral; Alopecia; Androgen Antagonists; Female; Hair; Health Knowledge, Attitudes, Practice; Humans; Minoxidil; Patient Education as Topic; Self Care; Spironolactone; Stress, Psychological; United States; Women's Health | 2009 |
Innovative use of spironolactone as an antiandrogen in the treatment of female pattern hair loss.
Topics: Adolescent; Adult; Alopecia; Androgen Antagonists; Female; Humans; Male; Middle Aged; Minoxidil; Off-Label Use; Polycystic Ovary Syndrome; Spironolactone; Therapies, Investigational; Young Adult | 2010 |
Treatment of female pattern hair loss with the androgen receptor antagonist flutamide.
Topics: Adult; Alopecia; Androgen Receptor Antagonists; Drug Therapy, Combination; Female; Flutamide; Hair; Humans; Minoxidil; Spironolactone; Treatment Outcome | 2011 |
Menopause management: how you can do better.
Topics: Acupuncture Therapy; Adjuvants, Immunologic; Administration, Cutaneous; Administration, Topical; Affect; Age Factors; Androgen Antagonists; Androgens; Antidepressive Agents; Antidepressive Agents, Second-Generation; Atrophic Vaginitis; Azabicyclo Compounds; Bupropion; Cyproterone Acetate; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Dyspareunia; Estrogens; Eszopiclone; Exercise; Female; Hair; Hormone Replacement Therapy; Hot Flashes; Humans; Hypnotics and Sedatives; Libido; Life Style; Lubricants; Menopause; Middle Aged; Mineralocorticoid Receptor Antagonists; Minoxidil; Phytotherapy; Piperazines; Sleep Initiation and Maintenance Disorders; Spironolactone; Testosterone | 2012 |
Permanent scalp alopecia related to breast cancer chemotherapy by sequential fluorouracil/epirubicin/cyclophosphamide (FEC) and docetaxel: a prospective study of 20 patients.
Topics: Adult; Aged; Alopecia; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Cyclophosphamide; Docetaxel; Epirubicin; Female; Ficusin; Fluorouracil; Humans; Middle Aged; Minoxidil; Prospective Studies; Spironolactone; Taxoids; Ultraviolet Therapy; Vitamins | 2012 |
Hair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapy.
Topics: Administration, Cutaneous; Adult; Alopecia; Drug Therapy, Combination; Estradiol; Estrogens; Humans; Male; Mineralocorticoid Receptor Antagonists; Minoxidil; Sex Reassignment Procedures; Spironolactone; Transsexualism; Vasodilator Agents | 2012 |
Androgenic alopecia: an entity to consider in adolescence.
Topics: Adolescent; Alopecia; Contraceptives, Oral, Hormonal; Female; Humans; Mineralocorticoid Receptor Antagonists; Minoxidil; Spironolactone | 2017 |
Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Diuretics; Drug Combinations; Female; Humans; Middle Aged; Minoxidil; Pilot Projects; Prospective Studies; Severity of Illness Index; Spironolactone; Urticaria; Vasodilator Agents; Young Adult | 2018 |
Female pattern hair loss.
Topics: 5-alpha Reductase Inhibitors; Adult; Alopecia; Androgen Receptor Antagonists; Female; Humans; Minoxidil; Risk Factors; Spironolactone; Vasodilator Agents | 2018 |
Assessment of Quality of Life and Treatment Outcomes of Patients With Persistent Postchemotherapy Alopecia.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Agents; Cohort Studies; Female; Humans; Middle Aged; Minoxidil; Quality of Life; Retrospective Studies; Severity of Illness Index; Spironolactone; Surveys and Questionnaires; Treatment Outcome; Young Adult | 2019 |
Combination oral minoxidil and spironolactone for the treatment of androgenetic alopecia in adolescent girls.
Topics: Administration, Oral; Adolescent; Alopecia; Dermoscopy; Drug Therapy, Combination; Female; Hair Follicle; Humans; Minoxidil; Retrospective Studies; Severity of Illness Index; Spironolactone; Treatment Outcome | 2021 |
Dermoscopic evaluation of the efficacy of combination of topical spironolactone 5% and minoxidil 5% solutions in the treatment of androgenetic alopecia: A cross sectional-comparative study.
Topics: Administration, Topical; Alopecia; Cross-Sectional Studies; Double-Blind Method; Female; Humans; Male; Minoxidil; Spironolactone; Treatment Outcome | 2022 |